ABCC drug efflux pumps and organic anion uptake transporters in human gliomas and the blood-tumor barrier
C., Senior, A
Priority research needs include large-scale randomized controlled trials to establish efficacy and safety, dose-ranging studies to optimize treatment protocols, long-term safety studies particularly regarding cancer risk, and comparative effectiveness research with established therapies
Erin Palinksi-Wade, a registered dietician and board certified advisory member of Replenza, a new physician-formulated supplement system for GLP-1 users, says: There is a big interest in supplements that support the nutritional needs of GLP-1 users, partly because it is really hard for them to get everything they need nutritionally when theyre eating such a small amount of calories, but also to offset the side effects they can experience. As many as 68% of GLP-1 users stop taking the medications within one year, and Dr Alexandra Sowa, who specialises in internal and obesity medicine and has worked with GLP-1 patients for over a decade, says that the side effects can be difficult to navigate
Its main job is to help regulate blood sugar by prompting your pancreas to release insulin (which lowers blood sugar) and by reducing the release of glucagon (which raises blood sugar)
